Differentiated Therapeutics
Latest round
- Seed
Last raised
- Aug 2022
Total raised
- $5M
Investors
- 1
About Differentiated Therapeutics
Based in California, US, and founded in 2021 by CEO Bryce Allen, COO Diala Ezzeddine, and co-founder Isaac Kohane, Differentiated Therapeutics, Inc. operates as a developer of computationally predicting and optimizing targeted protein degraders (TPDs) and transformative medicines. Differentiated Therapeutics, Inc. designs and develops disease modifying TPD therapies for patients with unmet medical needs. The company offers targeted protein degradation (TPD), a novel protein degrader, to eliminate the genetically defined drivers of disease. In addition, the firm provides an automatic differentiation (Auto/dx) platform, a collection of tools that enable differentiable portfolio planning by screening a differentiated therapeutic knowledge graph (DTKG) to identify protein degradation strategies for targets with indications of high unmet needs.
Who invested in Differentiated Therapeutics
1 investor across 1 round
See all investors in Differentiated Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 1, 2022
Amount
$5M
Investors
Questions about Differentiated Therapeutics
Who invested in Differentiated Therapeutics?
Differentiated Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Differentiated Therapeutics raised?
Differentiated Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Differentiated Therapeutics last raise money?
Differentiated Therapeutics's most recent round on record is a Seed, in Aug 2022.
What does Differentiated Therapeutics do?
Based in California, US, and founded in 2021 by CEO Bryce Allen, COO Diala Ezzeddine, and co-founder Isaac Kohane, Differentiated Therapeutics, Inc.
Where is Differentiated Therapeutics headquartered?
Differentiated Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Differentiated Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Differentiated Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Differentiated Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.